Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for prescription drugs, President Donald Trump told reporters on Sunday that he had cut costs by up to 1,

"We've cut drug prices by 1,200, 1,300, 1,400, 1,500 percent. I don't mean 50 percent. I mean 14-, 1,500 percent," Trump said.

Pfizer increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and “confidence” that strength seen in the first half of the year will continue.